PB Fintech runs Policybazaar, India's largest online insurance marketplace, alongside credit aggregator Paisabazaar, and reports into a quarter where industry standalone health premium grew 27-30% every month and life new business premium grew 20-33%. The print will speak to two things: whether the company stays on track for its Rs. 1,000 Cr PAT target for FY27, and how management addresses the IRDAI consultation paper on insurance distribution economics released inside the quarter.
| Results date | October 30, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 1,888 Cr (+40% YoY) |
| Previous quarter PAT | Rs. 163 Cr (+92% YoY) |
| Previous quarter EBITDA margin | Adjusted EBITDA Rs. 186 Cr (+109%), 10% of revenue |
| Market cap | Rs. 46,939.29 Cr |
| CMP | Rs. 1,008.4 |
The Board of Directors meets on October 30, 2026, to consider the Q2 and H1 FY27 financial results, with the trading window shut till November 1.
The Q2 FY27 earnings call is scheduled for October 30, 2026, at 6:00 PM IST. Attendees include Yashish Dahiya, Alok Bansal, Sarbvir Singh, Santosh Agarwal and Mandeep Mehta.
The Board did not recommend any dividend for FY26, stating an intent to reinvest profits for growth. This was disclosed with the FY26 AGM notice and annual report in September 2026.
The quarter's central question is whether PB Fintech can hold its operating-leverage trajectory — fixed-cost growth guided at 15-20% against core ex-Savings growth guided at 35-45% and take rates maintained at 16-18% — while the IRDAI consultation paper 'Recalibrating Economics of Insurance Distribution', released September 23, 2026, hangs over guidance credibility. The demand backdrop into the print is a tailwind: industry standalone health premium grew 27-30% every month through the quarter and life new business premium grew 20-33%, against which PB Fintech's protection book grew +53% in Q1 FY27, well above the industry's ~17% life NBP growth. The FY27 scorecard still has runway but demanding arithmetic — trailing-12-month PAT of Rs. 748 Cr as of Jun-26 is Rs. 252 Cr short of the Rs. 1,000 Cr FY27 target, requiring acceleration through the remaining quarters. The commission-cap proposals do not bite this quarter's numbers since they are consultation-stage with implementation under consideration for January or April 2027 and a five-year phase-in, but the stock's 36% single-session fall on the paper's release shows how the market prices the overhang. A late-quarter swing factor is savings demand: fresh savings grew +20% in Q1 despite choppiness, but the Nifty fell 6.3% in September — its worst September series since 2001 — so savings momentum likely faded into quarter-end. Management has also asked investors to judge the business on a 12-month rolling basis rather than quarterly numbers, a framing likely to recur on the call.
Guidance scorecard: FY27 targets: Management's FY27 commitments are the first thing to probe on the call.
IRDAI distribution-economics overhang: The consultation paper is the dominant regulatory item for this call.
Base effects, savings and credit recovery: Comparison bases and the savings swing leg will shape how the print reads.
UAE momentum and new product launches: Growth mix within New Initiatives and early product uptake.
The company's Q4 FY26 slide states it is 'On track for Rs. 1,000 Cr PAT in FY27'. Trailing-12-month PAT as of Jun-26 was Rs. 748 Cr, leaving Rs. 252 Cr to add through the remaining quarters.
The paper proposes first-year commission caps of 5-20% for distribution entities and 6.25-25% for agents, with implementation under consideration from January or April 2027 phased over five years. Management said the proposed limits 'may not fully reflect the operational and servicing cost structures of online insurance distribution' and that it will submit detailed feedback.
Management guided that insurance take rates will be maintained at 16-18%, noting its customer book has a claims ratio below 80%. It also said 'Our take rates have never changed... I would always welcome reduction in take rates as long as the benefit does get passed on to the consumer'.
Management has guided that New Initiatives adjusted EBITDA will be 'very close to zero' by FY27, saying 'I said FY27, not FY30. Next year, it should be very close to adj. EBITDA zero'. In Q1 FY27 the segment posted an adjusted EBITDA loss of Rs. 36 Cr on a (5)% margin.